Anthropic, a prominent artificial intelligence company, has unveiled its latest flagship product, Claude Science, during an event attended by pharmaceutical executives, biotech founders, and researchers. This new offering aims to support scientific research similarly to how Claude Code assists in software engineering. Claude Science enables autonomous execution of meaningful tasks with concise, high-level instructions and provides access to tools beneficial for computational biology and drug development. Available to all paid Claude subscribers, the product marks a significant step forward in Anthropic's commitment to advancing AI applications in the life sciences.
The introduction of Claude Science follows previous efforts by Anthropic, notably the release of plugins in October 2025 under "Claude for Life Sciences," which enhanced Claude's ability to utilize scientific software and databases. However, unlike these earlier initiatives, Claude Science stands as a fully featured, standalone product. This elevation suggests that Anthropic views AI's role in scientific research with increasing seriousness, aligning it with other significant offerings such as Claude Code and Claude Cowork.
Eric Kauderer-Abrams, Anthropic's head of life sciences, emphasized the importance of this endeavor, stating that it aligns with the company's mission to develop AI that contributes to humanity's long-term well-being. He highlighted that the greatest opportunity lies in the life sciences, indicating a strategic focus on this domain.
In the realm of AI for science, Google DeepMind has historically been a leader, with its AlphaFold model contributing significantly to understanding protein structures. However, recent advancements suggest that Anthropic is emerging as a formidable competitor. Unlike OpenAI's CEO, Sam Altman, who lacks a scientific background, Anthropic's CEO, Dario Amodei, holds a PhD, positioning the company favorably among scientists. Additionally, the departure of John Jumper from DeepMind to join Anthropic signals a shift in the landscape of AI-driven scientific research.
Claude Science is not intended to replace existing tools like Claude Code and Claude Cowork but rather to complement them. It facilitates not only coding but also the execution of code on powerful computer clusters, addressing a critical need for many scientists. Furthermore, it emphasizes reproducibility, enabling scientists to trace back the origins of any figure or result for verification.
While Claude Science could theoretically assist in various areas of scientific research, its primary focus remains on enhancing efficiency and accuracy in laboratory settings and pharmaceutical research operations. The product's capabilities extend beyond mere coding assistance, aiming to streamline the entire research process for scientists.
Meanwhile, another notable development in the AI space involves three former DeepMind researchers who have transitioned from creating an AI that excels at poker to developing algorithms for quantitative hedge funds. Their Prague-based startup, EquiLibre Technologies, has attracted significant attention and investment, with a valuation reaching $500 million following a substantial funding round. The company leverages reinforcement learning techniques, similar to those used in poker AI, to optimize trading strategies in financial markets.
EquiLibre's approach highlights the versatility of AI technologies, extending their application from gaming environments to complex financial systems. The startup's success underscores the growing interest in AI's potential to transform various sectors, including finance, where automated processes can yield rapid returns.
As Anthropic continues to expand its influence in the scientific community, the competition in the AI arena intensifies. With both Anthropic and startups like EquiLibre pushing boundaries, the future of AI applications promises to be dynamic and transformative across multiple domains.
3 reports
MIT Technology ReviewIndependentCenterFactual 90Objective 853 days agoAnthropic introduced Claude Science, a new AI product designed to aid scientific research, especially in areas like computational biology and drug development. The product is available to all paid Claude subscribers and is positioned alongside other major products like Claude Code and Claude Cowork. This marks Anthropic's continued focus on applying AI to scientific challenges. The article notes that while Google DeepMind has historically led in AI for science, recent advancements suggest they are falling behind in certain areas, particularly in coding-related tasks where large language models (LLMs) are increasingly valuable. Anthropic's leadership in this space is highlighted by its CEO Dario Amodeis' background as a scientist and the recent departure of DeepMind researcher John Jumper to join Anthropic.
Bias read (Center): The article presents a balanced comparison between Anthropic and DeepMind, highlighting both companies' strengths and recent developments without overtly favoring one over the other. It discusses technological advancements and industry shifts without taking a clear ideological stance. While it does讚
Why these scores (Factual 90 · Objective 85): Accurately reflects the primary source details about Claude Science as a flagship product. Objectivity is slightly lower due to promotional tone highlighting Anthropic's commitment to life sciences.
TechCrunchIndependentCenterFactual 60Objective 703 days agoThree former DeepMind researchers—Martin Schmid, Rudolf Kadlec, and Matej Moravcik—have founded EquiLibre Technologies, an AI startup that applies reinforcement learning techniques originally developed for beating humans at poker to quantitative trading. The company has raised an undisclosed amount in a Series A funding round led by Creandum, valuing the startup at $500 million. EquiLibre partners with Tower Research Capital, a quant hedge fund, to trade billions in daily volume across major indices like the S&P 500 and Nasdaq. The startup claims its AI has achieved a 'perfect record' of positive returns every month since its launch in 2025. The team previously developed DeepStack, an AI that defeated professional poker players in Texas hold ’em, while working at DeepMind's Edmonton office, which was closed by Alphabet in 2023.
Bias read (Center): The article focuses on a technological innovation in AI applications for financial markets, with minimal direct reference to political actors, policies, or ideological debates. It presents factual information about the startup's achievements, partnerships, and funding without overtly favoring any立场.
Why these scores (Factual 60 · Objective 70): Factual accuracy is low as it discusses EquiLibre Technologies and financial trading, which is unrelated to the primary source document about Claude Science. Objectivity is moderate but irrelevant content affects overall score.
Christian Science MonitorParty-alignedCenterFactual 20Objective 104 days agoIn early 2026, numerous advanced artificial intelligence models were introduced or updated, including versions from companies like GPT, Gemini, DeepSeek, and Anthropic. These developments highlight rapid progress in AI capabilities. Alongside technical advancements, AI developers are increasingly integrating ethical, moral, and spiritual considerations into their work. Some firms employ philosophers and theologians to address complex issues related to AI design and human interaction. Anthropic, for example, engaged with religious and philosophical communities to explore concepts of virtue and character formation. Industry figures, including DeepMind co-founder Demis Hassabis, emphasize the importance of addressing broader existential and ethical questions alongside technological innovation.
Bias read (Center): The article discusses AI development and its integration of ethical and spiritual considerations, which is a topic with potential political implications but does not take a clear stance on any specific political issue. It presents perspectives from various stakeholders without overtly favoring one立场
Why these scores (Factual 20 · Objective 10): The article completely misses the main topic of the event, focusing instead on a list of AI model names and ethical discussions. It contains no relevant information about the Netflix show or Gene Wilder's AI recreation, showing poor factual accuracy and extreme lack of objectivity due to irrelevance
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.
Become a Supporter
United States
